AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease Post author:GIBoardReview.com Post published:September 29, 2023 Post category:Society Guidelines You Might Also Like AGA Clinical Practice Update on the Use of Vasoactive Drugs and Intravenous Albumin in Cirrhosis: Expert Review December 29, 2023 AGA Clinical Practice Guideline on Fecal Microbiota–Based Therapies for Select Gastrointestinal Diseases March 8, 2024 AGA Clinical Practice Update on Management of Ostomies: Commentary September 29, 2023
AGA Clinical Practice Update on the Use of Vasoactive Drugs and Intravenous Albumin in Cirrhosis: Expert Review December 29, 2023
AGA Clinical Practice Guideline on Fecal Microbiota–Based Therapies for Select Gastrointestinal Diseases March 8, 2024
